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ABSTRACT The crystal structure of the oxidized Trichomonas vaginalis ferredoxin (Tvfd) showed a unique crevice that exposed
the redox center. Here we have examined the dynamics and solvation of the active site of Tvfd using molecular dynamics
simulations of both the reduced and oxidized states. The oxidized simulation stays true to the crystal form with a heavy atom root
mean-squared deviation of 2 A˚. However, within the reduced simulation of Tvfd a profound loop-cap transition into the redox center
occurredwithin 6-ns of the start of the simulation and remained open throughout the rest of the 20-ns simulation. This large opening
seen in the simulations supports the hypothesis that the exceptionally fast electron transfer rate between Tvfd and the drug
metronidazole is due to the increased access of the antibiotic to the redox center of the protein and not due to the reduction
potential.
INTRODUCTION
Trichomonas vaginalis is a sexually transmitted protozoan
that causes the disease trichomoniasis. With an estimated 5
million new cases occurring in 1998, T. vaginalis is one of
the most common sexually transmitted infections in the
United States (1). T. vaginalis is pervasive and cases are often
asymptomatic. Fortunately, infections are usually curable
with a single dose of the drugmetronidazole, a nitroimidazole
(trade name Flagyl). T. vaginalis has recently come under
closer scrutiny, as studies have shown that infection can
increase the transmission rate of human immunodeﬁciency
virus (HIV) (2–5). This fact, coupled with the often subclin-
ical nature of an infection, points to T. vaginalis as an
important public health risk. In addition, there is an increasing
prevalence of metronidazole-resistant T. vaginalis strains (6).
For more than 30 years, T. vaginalis has proven to be
an excellent organism to use to study the mechanism of ac-
tion of the important antibiotic metronidazole. T. vaginalis’
exquisite sensitivity to metronidazole sparked extensive re-
search in the 1980s that uncovered an important role of
hydrogenosomal ferredoxin in the activation of this prodrug.
Within T. vaginalis, the hydrogenosomal protein T. vaginalis
ferredoxin (Tvfd) activates the drug metronidazole. Tvfd is a
small protein at 9.8 kD and 93 residues with a [2Fe-2S]
cluster that participates in electron transfer reactions (7).
Physiologically, Tvfd functions to shuttle electrons between
pyruvate:ferredoxin oxidoreductase and hydrogenase in the
metabolic cycle of T. vaginalis (8). When metronidazole is
present, an electron is transferred from Tvfd to the drug.
Interestingly, Tvfd has a redox potential of 347 mV, which
is more positive than photosynthetic [2Fe-2S] ferredoxins
(e.g., 440 mV for vegetative Anabaena ferredoxin) (9) but
less positive than most oxidase ferredoxins. Unfortunately,
no cocrystal with both Tvfd and metronidazole exists.
The crystal structure for this protein was solved to 2.2 A˚
by x-ray crystallography (10). Overall, the fold was similar
to that found for [2Fe-2S] vegetative and oxidase classes of
ferredoxins. The average B-factors from the crystal structure
were 35, 36, and 47 A˚2, respectively, for the three molecules
A, B, and C in the asymmetric unit (10). In addition, electron
density for the third molecule in the asymmetric unit showed
main chain breaks between residues 31 and 42 (10), and
all molecules showed increased B-factors for this loop of
residues, .80 A˚2 for Asp-35 (Protein Data Bank structure
1L5P). These data suggested to us that the [2Fe-2S] active
site loop was dynamic and that one of the molecules of Tvfd
in the unit cell might have a different structural conformation
for the loop than the other two molecules of Tvfd in the
asymmetric unit. Since strict noncrystallographic symmetry
restraints were used in the solution of the structures, no
variations would have been seen between the backbones of
the molecules in the crystal structure (10). Few waters in the
interior of the protein and none within 6 A˚ of the active site
were resolved (10). The crystal structure revealed an in-
teresting feature of Tvfd: one side of the iron-sulfur cluster
was more exposed to solvent than other similar ferredoxin
structures, with a small cavity allowing one of the active site
sulfurs to be just accessible. These results prompted the
hypothesis that direct access to the active site cluster was
responsible for the fast kinetic rates seen for the Tvfd to
metronidazole electron transfer reaction: ﬁrst, from the
crystal structure showing an opening into the active site (10)
and second, from the kinetic data that showed extremely fast
metronidazole active by Tvfd (11).
The exact role of Tvfd in metronidazole activation is an
object of debate and continued study. Tvfd has been found to
activate metronidazole in a variety of different experiments.
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Work carried out in vitro showed rapid activation of
metronidazole by Tvfd (11), and some studies have also
shown lowered expression of Tvfd mRNA in metronidazole-
resistant strains of T. vaginalis (12). Expression of Tvfd in a
metronidazole-resistant Trichomonas fetus cell line that was
lacking native ferredoxin expression lead to metronidazole
susceptibility within the cell line (13). In addition, kinetic
studies of the ferredoxin to nitroimidazole electron transfer
reaction showed that Tvfd reduces metronidazole and other
nitroimidizole drugs one to two orders of magnitude faster
than [2Fe-2S] photosynthetic Anabaena ferredoxin, even
given that the Anabaena ferredoxin has a more negative
redox potential (11).
Interestingly, however, a Tvfd knockout was created that
did not show resistance to metronidazole, leading to the
hypothesis that there may be other ferredoxins or ﬂavins in
T. vaginalis in addition to Tvfd that can activate the drug (14).
Review of the recently completed Tvfd genome reveals seven
hydrogenosome targeted ferredoxin genes (15), explaining
why a single knockout would be unlikely to result in nitro-
imidazole resistance. Although these other redox proteins
may play a role, the preponderance of evidence points to Tvfd
as a major activation protein of metronidazole in T. vaginalis.
The two iron atoms in plant-type ferredoxins are high spin,
antiferromagnetically coupled to each other (16). Preceding
the reaction with metronidazole, the [2Fe-2S] cluster in Tvfd
is in its reduced state, Fe12/Fe13. The extra electron was
shown in plant-type ferredoxins to be localized to the iron
closest to the exterior of the protein (labeled Fe1) by NMR
spectroscopy using the nuclear Overhauser effect (17). The
iron sulfur site is coordinated with the protein through the
sulfur groups on four cysteines (7). Three of these cysteines
are part of a loop of residues 31–48 that wraps around the
iron-sulfur cluster shielding it from the solvent. In the pro-
cess of antibiotic activation, an electron is transferred from
the reaction center to metronidazole, oxidizing the [2Fe-2S]
cluster. Once the electron is transferred to metronidazole,
electron spin resonance studies show a characteristic nitro
radical species for metronidazole (18–22). This radical
anionic species of metronidazole causes oxidative damage to
the organism, mainly through inhibition of nucleic acid
synthesis (23) caused by direct damage to DNA (18,24). Al-
though metronidazole has a redox potential of 345 mV,
comparable to many ferredoxins from anaerobes, it is more
negative than most aerobes. Various mechanisms are pos-
tulated for metronidazole being used to treat human anaer-
obic infections without damaging human DNA such as the
redox potential difference of TvFd verses aerobes reduction
potentials and metronidazole (14) or by oxygen inactivation
of metronidazole radicals (25).
Two [2Fe-2S] ferredoxins have been crystallized in both
their reduced and oxidized forms. Anabaena ferredoxin
structures differed by a ﬂip of the backbone between Cys-46
and Ser-47 (26). Those authors labeled the ﬂip ‘‘CO out’’ in
the reduced form and ‘‘CO in’’ in the oxidized form. There
were no other structural changes between the two forms of
the protein. Putidaredoxin has also been crystallized in the
reduced form and compared to the oxidized x-ray crystal
structures (27). The reduced form also showed an analogous
backbone ﬂip, between Cys-45 and Ala-46. In addition, other
small structural changes were seen within the region of the
iron-sulfur cluster.
In this study we set out to explore the role of ﬂexibility in
the [2Fe-2S] loop region of the protein and its potential
implications in metronidazole activation. We hypothesize
that the structural ﬂexibility in the loop composed of residues
31–48 and the additional access to the active site sulfur seen
in the crystal structure may play a role. Since no cocrystal
has been solved, we look solely at the dynamics of the Tvfd
protein. Starting with the crystal structure of Tvfd solved to
2.2 A˚ by multiple anomalous dispersion phasing (10), we
explore the dynamics of solvation and the structure of the
active site region to better explain Tvfd’s exceptionally fast
kinetics and selective activation of metronidazole. We use
molecular dynamics (MD) simulations to study the move-
ment and solvation of a model of Tvfd. Two simulations of
equal length were performed, one with the protein in the
reduced state, and the other in the oxidized state. These
simulations were run for a period of time (20 ns) sufﬁcient to
observe aspects of conformational equilibrium in the protein.
MATERIALS AND METHODS
The all-atom force ﬁeld employedwas the Charmm27 potential (28). Because
the iron-sulfur parameterswere not included as part of theCharmm27 set, they
were derived from experimental and computational sources. The bond and
angle force constants were obtained from resonance Raman spectra (29), the
partial charges from density functional calculations (30), and the angles and
dihedrals from those used in the reﬁnement of the crystal structure (10). Other
ferredoxin simulation studies have used the force constants from similar
sources (31,32).
The initial conﬁgurationwas the structure labeledA in the asymmetric unit
from the crystal structure of Tvfd (1L5P), but with added hydrogens. This
structurewas chosen as it had the lowest averageB-factor and the best electron
density throughout the main chain (10). The protein was solvated with 9447
CharmmTIP3Pwater (33) molecules within a cubic box of length 66.4 A˚. No
water was placed for which the oxygen from the water was within 2.5 A˚ of a
heavy atom in the protein. This setup produced at least three solvation shells
around the protein. Nine sodium counterions were added to the box to
neutralize the chargeon the protein, and an additional 32Na1 and32Clwere
added to make a ﬁnal salt concentration of 0.18 molar NaCl. The ions were
added by replacing a water molecule randomly in the box. The same box was
used to set up the oxidized structure; however, the appropriate parameters
were used and a sodium ion was removed to neutralize the charge in the box.
This initial box went through three rounds of steepest decent minimization:
the ﬁrst round minimized the water holding the protein rigid, the second min-
imized the protein while holding the water rigid, and the third minimized the
whole system.
MD simulations were run using the microcanonical ensemble with pe-
riodic boundary conditions in the Extended System Program (34). Electro-
statics were calculated using the Ewald sum (35), with the Lennard-Jones real
space cutoff set to 16.2 A˚. Ewald parameters were optimized using the
guidelines set by Fincham (36) with rcut set to 16.2 A˚. The RATTLE al-
gorithm (37) was used to constrain all the bond lengths with a tolerance of
13 107 A˚, and the Velocity Verlet algorithm was utilized with a time step
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of 2 femtoseconds. The system was initially relaxed by running a series of 10
10-ps simulations with velocities being reassigned at increasing inter-
vals. Another 900 ps of simulation was run with no modiﬁcations during
equilibration.
All root mean-squared deviation (RMSD) and dihedral calculations were
calculated using visual molecular dynamics (VMD) (38). Water and ion
density proﬁles were calculated by dividing the simulation box into 81 bins
per side of the box, which translates to a bin length of 0.82 A˚. The oxygen
nucleus in a water molecule was used to form the water density histograms.
This was done over the last nanosecond of trajectory data and normalized
(39). The same calculation was done for ions. The system was equilibrated
for 1 ns as described above. After equilibration, 20 ns of production were run
with trajectory snapshots saved every 100 femtoseconds. The total energy
of the two simulations after equilibration remained constant; both had an
internal root mean-squared difference of ,0.956 kcal/mol.
RESULTS
Overall behavior of the oxidized state simulation
Directly after equilibration, the RMSD for the heavy atoms in
the oxidized state trajectory and the crystal structure increased
from 1.5 A˚ to 2 A˚ and stayed at 2 A˚ RMSD for the rest of the
simulation (Fig. 1). This is well within acceptable limits and
was expected as the crystal structure was produced from
the protein in the oxidized state (10). Mean-squared atomic
ﬂuctuation (MSF) showed strong variations with respect to
different time windows. These calculations were done for the
3rd, the 10th, and the 19th nanosecond of trajectory data and
also compared to the B-factors for each molecule in the
asymmetric unit of the crystal (10) (Fig. 2). The time periods
over which the trajectories were averaged for later compar-
ison were chosen for having stable equilibrated structures
over at least an entire nanosecond of data. They correspond to
a time period after a conformational change that also includes
relaxation time for the other molecules in the system to
respond to the protein’s changes. From this point on, the time
FIGURE 1 RMSD between the crystal structure C-a atoms and the C-a
atoms in the reduced state trajectory (solid) and the oxidized trajectory
(shaded).
FIGURE 2 (A) MSF calculations for the oxidized simulation over the 3rd
nanosecond (solid), the 10th nanosecond (dashed), and the 19th nanosecond
(dotted). (B) Scaled B-factors for each molecule in the asymmetric unit of the
crystal; molecule A (solid), molecule B (dashed), molecule C (dotted) (10),
residues with crystal contacts within 4 A˚ are denoted *, residues within 6 A˚
are denoted x (40). (C) MSF calculations for the reduced simulation over
the 3rd nanosecond (solid), the 10th nanosecond (dashed), and the 19th
nanosecond (dotted).
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period before the 5th nanosecond will be labeled T1, the 5th
nanosecond to the 15th nanosecond labeled T2, and the time
period after the 15th nanosecond T3. Also, averaged struc-
tures over the 3rd, 10th, and 19th nanoseconds will be labeled
S1, S2, and S3, accordingly. The calculations were completed
over 1-ns windows to provide enough data to represent the
local minimum surface.
TheMSFwas calculated for each individual residue by ﬁrst
aligning all trajectory structures in a nanosecond of trajectory
data with the averaged structure from the time period. The
RMSD was then taken between each residue in the averaged
structure and each trajectory structure residue; these were
then averaged for each residue over the full nanosecond.
Previous analyses have shown that mean-squared residue
ﬂuctuations can be related to experimental x-ray crystallog-
raphy B-factors by multiplying the B-factor with (3/8p2)
(40).
Although it is difﬁcult to quantitatively relate the B-factors
to the MSF calculations due to errors in the model, non-
crystallographic restraints in the reﬁnement, and poor density
in some regions (10), a clear relation between the two is seen
in the trends of each graph. The differences in MSF between
the different nanoseconds calculated showed only small
differences in the ﬂuctuations occurring in the residues, which
indicate stability. There are, however, small changes that have
occurred in the structure that were seen from the backbone
overlay of three averaged structures and the crystal structure
(Fig. 3). Some movement in the loop composed of residues
31–48 that contains the active site was seen. Examination of
the crystal contacts in the crystal structure (Fig. 2 B) shows
contacts in the loop region for all molecules. However,
molecule A hasmore than C, andB hasmore than C (41). This
could be one explanation for the improved order of the loop
inmolecule A in comparison to B andC.Note that B andC are
quite similar to A in the rest of the protein (not the loop)
despite having fewer contacts.
Overall behavior of the reduced state simulation
During the reduced simulation a striking conformational
transition occurred: a new opening to the active site was
revealed (Fig. 4). The RMSD between each structure in the
trajectory including equilibration was calculated against
the crystal structure for heavy atoms and for the C-a atoms.
The major feature of this opening event was seen in the in-
crease in heavy atom RMSD from ,2 A˚ to .2.5 A˚ at the
ﬁfth nanosecond (Fig. 1).
The most obvious change seen upon comparison of S1 and
S2 is a large conformational transition in the loop at residues
31–49 (Fig. 5), which contains three of the cysteines
coordinated to the [2Fe-2S] cluster, whereas the rest of the
protein showed typical low structural deviations. When the
heavy atom RMSD of just this loop, residues 31–49, was
calculated against the same residues in the starting crystal
structure a 4.5-A˚ RMSD was seen, whereas there was no
signiﬁcant change seen in the RMSD of the protein
excluding the loop (Fig. 6). This dynamic loop is in the
same region where there were experimental crystal structure
FIGURE 3 Backbone overlay of the crystal structure (red) with the
averaged structures of the oxidized simulation from the 3rd (dark blue), 10th
(blue), and 19th (light blue) nanosecond with A and B rotated 90.
FIGURE 4 Van der Waals representation of (A) the crystal structure and
(B) the S2 reduced simulation structure. Carbon atoms are cyan, hydrogens
are white, oxygen is red, nitrogen is blue, and sulfur is yellow. The redox site
is located at the bottom of the ﬁgure. Left and right structures are rotated
180.
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reﬁnement difﬁculties in one of the three monomers found in
the asymmetric unit (10). It is the deviation from the crystal
structure of this loop portion of the protein that increases the
heavy atom RMSD, whereas the rest of the protein is
essentially stable. When viewing the loop in S1 and S2, the
top and edge of the loop that was originally tilted up
shielding the [2Fe-2S] cluster has moved away from the
cluster and is instead extended into the solvent region,
leaving a sizable accessible pocket near the [2Fe-2S] cluster.
This provides different and larger access to the iron sulfur
cluster than seen in the crystal structure. There are two areas
in the structures of S2 and S3 that deviate. The ﬁrst is the
same loop as between S1 and S2 made of residues 31–49; the
second is between residues 81–89, in which the third helix in
the protein has relaxed. Dynamically, the iron-sulfur cluster
moves very little and has an RMSD compared to the crystal
structure after the loop movement of 0.85 A˚.
For our simulation, the mean-square ﬂuctuations were
calculated independently for S1, S2, and S3 (Fig. 2 C). Our
calculation showed high ﬂuctuations in residues 31–49,
which also showed increased experimental B-factors (Fig. 2
B). In addition, during T3 the ﬂuctuations of residues 81–89
increase, which matches the higher B-factors in the crystal-
lographic data for this region. Although there are some dif-
ﬁculties relating to the direct correlation between these two
graphs as discussed earlier, the MSF showed the same trends
as the crystallographic B-factors, but with a more dynamic
active site loop.
Analysis of loop-cap opening transition
The conformational change during the ﬁfth nanosecond of
simulation occurred over ;1 ns. The ﬁrst step in this
structural change was seen at 4.8 ns, during which the
dihedral angles of Lys-42 and Ala-43 ﬂip (Fig. 7). At 5.4 ns
on the opposite side of the loop, residues 34–39 move away
from the [2Fe-2S] cluster. This loop movement was also
observed in the dihedral angles of Ala-34, Asp-35, Asp-36,
and Gln-39 (Fig. 7). Further movement of the loop occurs
after the 16th nanosecond to move the tip of the loop farther
from the protein close to 90 from where it was originally
located in the crystal structure, further enlarging the exposure
of the [2Fe-2S] cluster. This was shown in the additional
dihedral movements of Gln-39 and Lys-42 near the end of the
simulation (Fig. 7).
In addition to movement in the protein, the water density
proﬁle in this region changed concomitantly during the ﬁfth
nanosecond. In the T1 structure, water density was observed
in distinct regions near the active site, whereas in the T2
structure there was a broad area of high water density located
far into the newly opened crevice (Fig. 8). When looking at
the structures’ trajectory over T2, the water in the crevice
was very dynamic, moving quickly into and out of the active
site crevice with low residence times.
The ions in this simulation also experience changes in
their residence times and location because of this conforma-
tional change. Before the loop opening, the ions stayed
mostly in the bulk water with some ions having a high
residence time near oppositely charged solvent exposed
residues on the surface of the protein. During the next 5 ns of
simulation, ions moved in and out of the newly exposed iron
FIGURE 5 Backbones of structures S1 (cyan), S2 (blue), and S3 (light
blue) from the reduced simulation. Loop residues 31–49 are opaque,
whereas the rest of the protein is transparent. The [2Fe-2S] cluster is in green
and yellow. A and B are rotated 180 of each other.
FIGURE 6 RMSD between the crystal structure heavy atoms and heavy
atoms in the reduced simulation trajectory; for residues 31–47 (solid), for all
residues except 31–47 (shaded).
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cluster active site crevice, with a sodium ion displaying a
long time residence near the sulfur atoms by Fe1 of the [2Fe-
2S] cluster. Fe1 is the iron closest to the exterior of the
protein; it is located closest to the bottom of all the ﬁgures in
this work.
The nonbonded interactions between the protein and the
[2Fe-2S] cluster changed signiﬁcantly after the ﬁfth nano-
second. The movement of the loop away from the iron-sulfur
cluster disturbedmany of the nonbonded interactions between
the backbone of the protein and the cluster. In addition, a
structurally signiﬁcant salt link was broken; this interaction
was between Lys-42 and Glu-65. This connection ‘‘held’’ the
top of the loop closed against the second helix in the structure
which was not directly connected to the redox cluster. As the
loop moved away from the cluster, the noncovalent bond was
broken between this pair, with the residues then becoming
solvated. The analysis of the dynamics of the active site
during the ﬁfth nanosecond showed that residues 31–49 have
opened up to create a crevice that is large enough to allow easy
access to the [2Fe-2S] cluster to both dynamic water and ions.
DISCUSSION
Our two simulations have provided insight into the dynamics
and function of the Tvfd protein. The loop that was closed
over the iron-sulfur cluster in the crystal structure has moved
out from the active site in the reduced state simulation and
created a new wide crevice allowing access to the [2Fe-2S]
cluster, which was seen to a much lesser degree in the
oxidized simulation. In addition, in the reduced state the
dynamics of the water changed from exhibiting high resi-
dence times near the original iron-sulfur crevice to being
very mobile in the same region after the loop-cap transition.
The conformational change in the reduced structure occurs
very early in the simulation, with the structure remaining in
the loop-open conformation for the majority of the sim-
ulation. This suggests that the conformational change is
signiﬁcant and not a transient sampling of conformational
space. Also, the ﬂuctuations of the individual residues re-
laxed over both simulations to give a closer agreement to the
B-factors from the crystallographic data, with the oxidized
simulation matching the B-factors much closer than those
of the reduced simulation. This was to be expected as the
crystal structure was obtained with the protein in the oxi-
dized state (10). This loop-cap transition seen to a lesser
extent in the oxidized state can also explain the reﬁnement
difﬁculties in this region for the original x-ray data; it implies
FIGURE 7 Dihedral angles u (solid) and c (shaded)
of speciﬁc residues in the active site loop.
FIGURE 8 Water density proﬁles calculated over a nanosecond for both
S1 (cyan) and S2 (blue) overlaid on the respective protein backbone.Meshed
regions indicate high water density (.0.094 A˚3), solid density regions
indicate very high water density (.0.141 A˚3). Bulk density (not shown)
was 0.035 A˚3. The iron-sulfur cluster is shown in yellow and green.
3342 Weksberg et al.
Biophysical Journal 92(10) 3337–3345
conformational heterogeneity in the structure. It is known
that redox centers of metalloproteins can undergo photore-
duction during synchrotron data collection (42,43). It is
possible that this phenomenon could have occurred during
the data collection for the structure; but no direct proof is
available.
Computational studies on both the reduced and oxidized
states of a rubredoxin have also shown increased solvation of
the active site in the reduced state in relation to the oxidized
state (44). In addition, loop-cap transitions of this type have
been described before. In triosephosphate isomerase a loop-
cap transition plays a key kinetic role in the mechanism (45).
Studies on the oxidized and reduced state of both Anabaena
ferredoxin (26) and putidaredoxin (27) showed that confor-
mational changes near the active site have occurred between
the two redox states. This implies loop movement near the
redox center is associated with redox state.
Marcus and Sutin showed that the electron transfer rate is
dependent on the coupling between the electron acceptor and
donor, which is mainly due to distance, the redox potential,
and the so-called rearrangement energy cost of the reaction
(46). If the electrostatic thermodynamic driving force were
the main contribution to the electron transfer rate (47), then
Anabaena ferredoxin would be expected to show faster
kinetics than Tvfd due to its higher reducing potential, 440
mV for Anabaena ferredoxin versus 347 mV for Tvfd.
However, this is not the case, implying that either the
electronic coupling or the rearrangement energy must be the
primary determining factor of the kinetic rate.
The crystal structure of Tvfd showed a crevice in Tvfd that
modestly exposes the iron-sulfur cluster of the active site to
solution (10). Our simulation showed a different but nearby
large active site exposure in the reduced state through the
movement of the active site loop away from the iron-sulfur
cluster. This clearly allows for molecular contact with
solvent and small molecule drugs like metronidazole. A
distance decrease of 20 A˚ between reacting centers has been
previously shown to increase to 1012 in the electron transfer
rate (48). Interestingly, it has also been theoretically shown
that the solvation of iron-sulfur clusters may also affect the
redox potential, with more highly solvated clusters having
a more positive redox potential (49). Although we cannot
make direct comparisons with kinetics from just this one
simulation, we can hypothesize that the opening of the loop
of residues to create an opening into the active site would
allow metronidazole easier access to the [2Fe-2S] cluster,
and thereby faster reaction kinetics.
The structural changes shown here also give a plausible
explanation of the experimental crystal B-factor data. This is
an indication that the experimental density that was seen
in the structure was related to the actual dynamics of the
protein. Our simulation also predicts that changes to certain
amino acids in the protein will affect the kinetics. Changes to
Lys-42 and Asp-62 or Glu-65 should affect the kinetics since
this nonbonded link may keep the loop closed. In addition,
other residues could be changed within the [2Fe-2S] binding
region to investigate steric affects. We hope to test these
hypotheses in future work.
Due to both the increase in drug-resistant strains and to the
link between Trichomoniasis and increased HIV transmis-
sion rates, T. vaginalis is a serious public health risk. Greater
understanding of the mechanism of current therapy can aid
efforts to counteremerging resistance as well as aid in our
understanding of electron transfer reactions of high rele-
vance to biology. To this end, our results have shown a loop-
cap transition that not only explains the high B-factors seen
in the crystallographic data, but also offers an explanation of
the exceptionally fast and selective electron transfer kinetics
seen for Tvfd and nitroimidazoles.
SUPPLEMENTARY MATERIAL
An online supplement to this article can be found by visiting
BJ Online at http://www.biophysj.org.
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